-transparent.png){kind=logo}
The effect of cyclosporin A administration on diabetes development following multiple low-dose streptozotocin treatment was determined in inbred mice. When given daily at a dose of 12 or 60 mg/kg body weight the drug induced an earlier development of hyperglycemia and led to persistently higher blood glucose levels. Enhancement of diabetes by cyclosporin A was also seen when the drug was given only after termination of treatment with streptozotocin.
Related Publications
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
January 1985,
Immunology letters,
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
October 1989,
Diabetes research (Edinburgh, Scotland),
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
March 1983,
Diabete & metabolisme,
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
May 1995,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
November 1987,
Diabetes research (Edinburgh, Scotland),
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
January 2001,
Environmental toxicology and pharmacology,
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
December 1996,
Biological & pharmaceutical bulletin,
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
April 2023,
bioRxiv : the preprint server for biology,
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
September 2023,
Physiological genomics,
H Kolb, and
M Oschilewski, and
E Schwab, and
U Oschilewski, and
U Kiesel
November 1978,
Nature,
